Position in TCRX
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$22,725
+$225 QoQ
Shares Held
22,500
0.0% QoQ
Ownership
0.034%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in TCRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026LPL Financial LLC holds $464,958,779 across 201 Biotechnology names. TCRX ranks #181 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
268,062 | $119,700,405 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
63,987 | $49,438,915 | |
| 3 | INSM |
INSMED Inc
|
138,281 | $22,611,709 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
67,637 | $22,379,054 | |
| 5 | EXEL |
Exelixis, Inc.
|
399,612 | $17,139,358 | |
| 6 | ARGX |
Argenx SE
|
23,247 | $16,976,121 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
194,304 | $12,557,867 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
378,656 | $10,488,771 |
All Filings in TCRX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $22,725 | 22,500 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $22,500 | 22,500 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $39,130 | 21,500 | Shares | Sole | 2025-11-12 | |
| 2023-03-31 | $25,200 | 12,000 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $26,350 | 17,000 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $45,750 | 15,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $50,320 | 16,000 | Shares | Sole | 2022-08-12 | |
| 2021-12-31 | $58,500 | 13,000 | Shares | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||